Klaudia P.’s Post

🔬 Ments Life Sciences Market Report 2Q/2024 is here! 🔬 Wondering what has happened and what's on the horizon in the Life Sciences sector in Slovakia? The Ments Life Sciences team has you covered! We've prepared a comprehensive summary of new challenges, amendments, laws, and upcoming legislation in our Life Sciences Market Report for 2Q/2024. 📈 Stay ahead of the curve with the latest insights and developments in this rapidly evolving field. Interested in getting our market report and staying updated? Contact Lukas Michalik or Klaudia P. – they will be more than happy to share the full Life Sciences Market Report with you. #ments #mentsattorneys #LifeSciences #marketreport

#Achema2024 is underway, and Rizwan Chaudhrey had a great discussion with Simon Alengrin about our capabilities and solutions, as well as our commitment to sustainability! Check out the link attached, and thank you to Rizwan Chaudhrey. #SaintGobainLifeSciences

An online database service that specializes in pharmacokinetic information. It contains more than 130,000 pieces of data on metabolizing enzymes (mainly cytochrome P450s) and transporters involved in drug absorption, distribution, metabolism, and excretion. It was based on data originally collected by Prof. Dr. Slobodan Rendić. The ADME Database contains information on substrates, inhibitors, inducers of drug-metabolizing enzymes, and drug transporters. The database also includes kinetic data related to the enzyme and transporter, classification of compounds as substrates, their reactions, chemical structures before and after metabolism, and related references (PubMed IDs). The database provides different searchable functions and detailed search results to meet various applications and users' needs. Further information is available at: https://lnkd.in/dUTbSprT. The HUMAN P450 AND TRANSPORTER METABOLISM DATABASE was developed from 1990–2002, and as research in the field of metabolism of xeno- and endobiotics after the year 1990 expanded, interest developed in providing the possibility of quick and systematic approaches to the published data. Thus, additional collection of the data was necessary regarding human P450s and, in addition, human transporter metabolism data. The first collective information on human P450 metabolism data was presented in tabular format as a part of the review published in 1997 (Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/dmr-120001392. PMID: 11996015) by S. P. Rendic and Dr. Frederick J. Di Carlo, a prominent toxicologist, who was executive editor of the journal Drug Metabolism Reviews and one of the founders of the scientific society ISSX (International Society for Xenobiotics, ISSX). The first collected data were organized as offline Excel format databases and were part of the web searchable databases by Gentest Corp., USA (1998–2002), and Fujitsu Kyushu Systems Ltd. Japan (FJQS) (2000-). The database development is presented in the paper by S. Rendić, F.P. Guengerich, Development and Uses of Offline and Web-Searchable Metabolism ADME Databases - The Case of Benzo[a]pyrene, Curr Drug Metab. 2018;19(1):3-46. doi: 10.2174/1389200219666171207123939, PMID: 29219051

Life sciences organizations have grappled with defining “normal” following the pandemic—but now, in 2024, there's the opportunity to turn incredible possibilities into reality. Explore the upcoming trends in our 2024 life sciences industry outlook! #2024 #SlalomLifeSciences #ImWithSlalom

Life sciences organizations have grappled with defining “normal” following the pandemic—but now, in 2024, there's the opportunity to turn incredible possibilities into reality. Explore the upcoming trends in our 2024 life sciences industry outlook! #2024 #SlalomLifeSciences #ImWithSlalom

Life sciences organizations have grappled with defining “normal” following the pandemic—but now, in 2024, there's the opportunity to turn incredible possibilities into reality. Explore the upcoming trends in our 2024 life sciences industry outlook! #2024 #SlalomLifeSciences #ImWithSlalom

Topic on Nitrosamie Aragen Life Sciences

Some thoughts on trends, challenges and opportunities for growth and investment in the life sciences sector in 2024.

Life sciences organizations have grappled with defining “normal” following the pandemic—but now, in 2024, there's the opportunity to turn incredible possibilities into reality. Explore the upcoming trends in our 2024 life sciences industry outlook! #2024 #SlalomLifeSciences #ImWithSlalom

Life sciences organizations have grappled with defining “normal” following the pandemic—but now, in 2024, there's the opportunity to turn incredible possibilities into reality. Explore the upcoming trends in our 2024 life sciences industry outlook! #2024 #SlalomLifeSciences #ImWithSlalom